Publication | Closed Access

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment

Delayed-onset Neurologic DiseaseViral PersistenceViral PathogenesisImmunologyAntiviral Drug DevelopmentVirologyAntiviral TherapyRibavirin TreatmentAntiviral DrugMedicine